Tania Rivera-Carranza

Dr. Tania Rivera-Carranza

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
TRTania Rivera-Carranza
Tania Rivera-Carranza
OMOralia Nájera Medina
Oralia Nájera Medina
RBRafael Bojalil-Parra
Rafael Bojalil-Parra
CRCarmen Paulina Rodríguez-López
Carmen Paulina Rodríguez-López
EZEDUARDO ZUÑIGA
EDUARDO ZUÑIGA
AAAlejandro Azaola-Espinosa
Alejandro Azaola-Espinosa
Background: Obesity, a public health problem, is a state of metainflammation that influences the development of chronic degenerative diseases, particularly in patients with severe obesity. Objective: The objective of this study was to evidence immunometabolic differences in patients with different degrees of obesity, including severe obesity, by determining correlations between lymphocyte subpopulations and metabolic, body composition, and clinical variables. Methods: Peripheral blood immune cells (CD4+, CD8+ memory and effector T lymphocytes) were analyzed, and measures of body composition, blood pressure, and biochemical composition (glucose, glycated hemoglobin (HbA1c), insulin, C-reactive protein (CRP), and the lipid profile) were carried out in patients with different degrees of obesity. Results: The patients were classified according to total body fat (TBF) percentage as normal body fat, class 1 and 2 obesity, class 3 obesity, and class 4 obesity. The greater the TBF percentage, the more pronounced the differences in body composition (such as a decrease in the fat-free mass (FFM) that is defined as sarcopenic obesity) and the immunometabolic profile. There was an increase of CD3+ T lymphocytes (mainly CD4+, CD4+CD62-, and CD8+CD45RO+ T lymphocytes) and an increase in the TBF percentage (severity of obesity). Conclusions: The correlations between lymphocyte subpopulations and metabolic, body composition, and clinical variables demonstrated the existence of a chronic, low-intensity inflammatory process in obesity. Therefore, measuring the immunometabolic profile by means of lymphocyte subpopulations in patients with severe obesity could be useful to determine the severity of the disease and the increased risk of presenting obesity-associated chronic degenerative diseases.

Verified
Journal Article
Open access
PDF file
TRTania Rivera-Carranza
Tania Rivera-Carranza
ALAngélica León-Téllez-Girón
Angélica León-Téllez-Girón
RGRaquel González
Raquel González
PVPaola Vázquez-Cárdenas
Paola Vázquez-Cárdenas
ACAna Laura Campos
Ana Laura Campos
RBRafael Bojalil
Rafael Bojalil
Obesity is considered a state of chronic low-grade inflammation that impacts the development of chronic degenerative diseases. Cellular immunity plays a crucial role in the onset and persistence of this inflammatory condition. As the degree of obesity increases, significant distinct immunometabolic alterations are observed compared to individuals with normal weight. Moreover, obese patients who undergo bariatric surgical procedures for weight loss exhibit changes in the proportion of immune cells. These alterations help to explain several molecular processes associated with inflammation in obesity, including protein activation and inactivation, precursor molecule synthesis, phosphorylation events, and the activation of signal transduction pathways, all of which are orchestrated by immune cells, primarily lymphocyte subpopulations. The study of the immunometabolic profile through lymphocyte subpopulations in obese patients can provide a more comprehensive and objective understanding of disease severity and the risk of developing obesity-related chronic degenerative conditions and thereby improve or propose therapeutic and novel approaches. Therefore, the objective of this narrative review is to offer an integrative perspective on the molecular and pathophysiological mechanisms through which lymphocyte populations contribute to obesity-related inflammation and how weight loss through bariatric surgical procedures may contribute to the therapeutic management of inflammation.

11 January 2025 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
TRTania Rivera-Carranza
Tania Rivera-Carranza
AAAlejandro Azaola-Espinosa
Alejandro Azaola-Espinosa
RBRafael Bojalil-Parra
Rafael Bojalil-Parra
EZEDUARDO ZUÑIGA
EDUARDO ZUÑIGA
ALAngélica León-Téllez-Girón
Angélica León-Téllez-Girón
OMOralia Nájera Medina
Oralia Nájera Medina
Background: Immunometabolism is the interaction between immune system and nutrient metabolism. Severe obesity is considered a state of meta-inflammation associated with obesity that influences the development of chronic-degenerative diseases. Objective: We aimed to establish the immunometabolic differences in bariatric patients and to determine whether cellular immunity is associated with metabolic changes. Methodology: We conducted an observational study in patients who underwent laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB). We explored the differences in the immunometabolic profile before and after surgery in the study group, by surgical technique, and we evaluated the changes in immunological variables as a function of metabolic variables with correlation analysis. Results: The follow-up rate was 88.7%. After the intervention, there were changes in cellular immunity, with a decrease in effector T lymphocytes (CD8+CD28−) and an increase in B lymphocytes, memory helper T cells, and cytotoxic T lymphocytes. LSG resulted in a greater decrease in (CD4+CD62−) T lymphocytes compared with LRYGB. Patients who underwent surgery with LRYGB presented greater clinical and metabolic improvements, as well as improvement of obesity-associated medical problems. Women who underwent LRYGB showed a greater reduction in fat-free mass compared with women who underwent LSG. Conclusion: Bariatric surgery, mainly LRYGB, leads to immunometabolic changes and improves associated medical problems. Graphical

23 May 2025 in Obesities
Verified
Journal Article
Open access
PDF file
TRTania Rivera-Carranza
Tania Rivera-Carranza
ALAngélica León-Téllez-Girón
Angélica León-Téllez-Girón
CMClaudia Mimiaga-Hernádez
Claudia Mimiaga-Hernádez
AAAdriana Aguilar-Vargas
Adriana Aguilar-Vargas
Obesity-Related Multimorbidity (ORM) is understood as the group of secondary diseases caused by metabolic alterations that arise from obesity. Nowadays there is a growing incidence of people with ORM who seek health services. Since this condition substantially impacts nutritional status and therefore in the survival prognosis during the hospital stay, ORM represents a challenge for health professionals. This forces doctors to specify nutritional recommendations according to clinical characteristics in individuals with obesity and types of comorbidities. Therefore, the objective of this narrative review is to present the current evidence-based recommendations that support the hospital nutritional care process for individuals with ORM. It concludes that nutritional treatment is complex and gaps in the research regarding this population group still exist. Because there are no specific guidelines for nutritional screening tools, calculating total energy requirements (alternatives to indirect calorimetry), determining fluid, protein, and immunonutrient requirements, the use of parenteral nutrition in ORM with kidney, liver, and heart failure and sarcopenic obesity that should be addressed in the new literature. For now, the standard practice in these cases is to prioritize the problem to be treated according to the maximum clinical benefit. Despite this, it is established that the nutritional care process must be systematic to be clear and objective. This document is addressed to all healthcare professionals who make up the multidisciplinary nutritional support team.

1 November 2023
Verified
Book Chapter
Closed access
TRTania Rivera-Carranza
Tania Rivera-Carranza
OMOralia Nájera Medina
Oralia Nájera Medina
AAAlejandro Azaola-Espinosa
Alejandro Azaola-Espinosa
Obesity is a major public health problem and is currently considered a pandemic. Some of the proposals for its treatment are the change of eating habits and lifestyle, as well as medical or surgical treatment. However, the current problem of obesity prompts the study of new preventive and / or therapeutic proposals since current therapies have not been sufficiently capable of reducing morbidity and mortality rates. The study of the gut microbiota in obesity is an important, broad field of information and novelty that is still in its infancy and therefore more information needs to be generated. Today, the gut microbiota is recognized to play an important role in health and disease. This work aims to demonstrate the relationship between the bacterial intestinal metagenome and obesity in humans. Therefore, a bibliographic review of the current literature was carried out to describe the characteristics of the intestinal microbiota and its participation in obesity. The search was carried out in the databases of Medline, PubMed, Google Scholar, Scopus, Cochrane, and Web of Science, between 2010 and 2020 of original articles and reviews. Finding that there are associations between the intestinal microbiota and metabolic, immunological, and neuroendocrine regulation in individuals with obesity. It is concluded that the metagenomic characteristics of the intestinal microbiota of individuals with normal weight compared to individuals with obesity are very different. Since in obese individuals, bacterial diversity and richness decrease notably, particularly due to the increase in Firmicutes phyla and the decrease in Bifidobacterium. Also emphasizing that the decrease in the genera Clostridium leptum, Faecalibacterium prausnitzii and Akkermansia muciniphila have an important role in the generation of immunometabolism alterations in the host. Therefore, the modification of the intestinal microbiota is a potential object of study to assist in the prevention and / or treatment of obesity.

27 November 2023
Verified
Book
Open access
PDF file
VRVerónica María Teresa Nava Rodríguez
Verónica María Teresa Nava Rodríguez
KRKarla Mónica Espinosa Reyes
Karla Mónica Espinosa Reyes
KDKarla Iveth González Díaz
Karla Iveth González Díaz
AOAnantli Itzel Hernández Ortiz
Anantli Itzel Hernández Ortiz
CLCarmen Paulina Rodríguez López
Carmen Paulina Rodríguez López
BRBárbara Fernández Robles
Bárbara Fernández Robles
Este libro contiene un conjunto de artículos científicos realizados en el contexto de la contingencia por COVID 19, desde los enfoques de las ciencias de la salud y las ciencias sociales. Su fin último es dar a conocer los avances científicos desde la perspectiva de género. De esta manera, la compilación incluye semblanzas de tres figuras relevantes de la academia mexicana: Ana Rosa López-Ferrari Aralia López González y Silvana Levi Levi con el propósito de sistematizar los aportes de cada una en los campos de la literatura, la botánica y la geografía respectivamente analizando de forma integral otros aspectos relevantes de lo que Bourdieu llamaría sus condiciones sociales de posibilidad. Por otro lado los artículos que conforman el libro se enfocan en: El estudio de posibles causas de la obesidad; exploraron los efectos psicológicos del confinamiento provocado por la pandemia por COVID 19 sobre los hábitos alimenticios y del sueño respectivamente; la experiencia exitosa de transformación cultivo de hortalizas de forma orgánica y sustentable durante un proceso de sobrevivencia y adaptación a las duras condiciones económicas y sociales producidas por la pandemia por COVID-19; La investigación con resultados alentadores, las características de sustancias que tentativamente puedan reemplazar aquellas con las que se trata el glioblastoma, de una manera más eficiente y con menos efectos colaterales; El incremento de los conflictos domésticos, la violencia por razones de género y feminicidios durante la pandemia; La valoración de los marcos de competencias digitales en España para diferentes áreas académicas en las que se implementó la educación a distancia con motivo de la pandemia por COVID-19.